Why the Autopsy Never Changes Anything
The deal died. We ran the post-mortem anyway.
The usual suspects show up in the notes: the internal advocate wasn’t strong enough, we didn’t get to the right people early enough, a competitor got in the door first, the timing was off. Everyone nods, the notes get filed, and next quarter a different deal dies the exact same way.
The Assumption Baked Into Every Deal Review
Every one of those explanations shares a hidden assumption: that the deal should have closed.
That assumption decides which question we ask next, and it points the question in exactly one direction, at what the seller did or didn’t do. An execution question can never produce any other kind of answer.
What the Question Should Actually Be
A complex buying decision doesn’t move through one person, and it doesn’t move in sequence. Several people are weighing, at the same time, whether to act at all, whether to build the thing internally or buy it, and who to trust with it. None of those decisions gets easier once another one resolves; the weight just shifts onto whoever hasn’t decided yet.
When one of those people can’t tolerate what the deal requires of them personally, the whole system settles wherever it can hold. Sometimes that resting place is no deal at all. Not because execution failed. Because that’s what the system could sustain, given who had to carry the risk.
That reframe changes the diagnostic question entirely. Instead of asking what went wrong, we ask what the constraint was, and whether it was one we could actually move.
Why We Keep Asking the Wrong Question Anyway
Every major sales methodology we’ve ever adopted attributes a loss to something the seller did, or to an irrational client. None of them have a category for a deal that resolved correctly, where the honest finding isn’t an error to fix, it’s a limit the buying system just showed us.
That’s an uncomfortable finding to sit with, because it can mean the deal was never winnable on our terms. Not because we sold it badly. Because the person who’d answer for it never had a way to say yes that didn’t cost them something they weren’t willing to risk.
Running the Review Differently
The fix isn’t complicated. It’s a different first question, asked before anyone touches the rep’s execution.
Who on the buying committee never fully engaged, and do we actually know why
What would that person personally have to answer for if this went wrong
Is that constraint something we can address, or something no vendor could have moved
If it’s movable, who owns the next call, and by when
Notice what’s missing from that list: the deck, the price, a harder pitch. None of those touch a constraint that lives inside one person’s job.
How This Shows Up in a Real Review
A client of ours ran every closed-lost review the same way for years: a checklist of what the rep should have done differently. We rebuilt the format around one question instead: who on the committee was actually constrained, and could that move. Deals that had been written off as dead started coming back, not because anyone sold harder, but because someone finally called the person who’d stopped answering and asked what had changed.
What This Actually Tells Us
A dead deal isn’t proof that we failed to sell. It’s the buying system telling us, as plainly as it had any way to, what it could not carry.
That’s not a failure to diagnose.
It’s information we didn’t have until we asked.